Ajai Chari

29PUBLICATIONS
101CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 09, 2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.

Sheri Skerget, Daniel Penaherrera, Ajai Chari

|Sep 16, 2024
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes.

Santiago Thibaud, Ryan L Subaran, Scott Newman

|Sep 12, 2024
Bispecific antibodies in the treatment of multiple myeloma.

Anup Joseph Devasia, Ajai Chari, Guido Lancman

|Aug 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.

Sheri Skerget, Daniel Penaherrera, Ajai Chari

|Aug 07, 2024
Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence.

J Martinez-Lopez, N Lopez-Muñoz, A Chari

|Jul 08, 2024
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.

Ajai Chari, Jonathan L Kaufman, Jacob Laubach

Pageof 5

Frequent Collaborators

6 joint publications

Sundar Jagannath

5 joint publications

Hearn Jay Cho

4 joint publications

Joshua Richter

3 joint publications

Saad Z Usmani